Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 2016

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 9
Chunk 2016
---
 of the work of the independent auditor (including resolution
                                            of disagreements between management and the independent auditor regarding financial reporting)
                                            for the purpose of preparing or issuing an audit report or related work;

64

●establishing
                                            procedures for the receipt, retention and treatment of complaints received by us regarding
                                            accounting, internal accounting controls or reports which raise material issues regarding
                                            our financial statements or accounting policies; and

●approving
                                            reimbursement of expenses incurred by our management team in identifying potential target
                                            businesses.

The Audit Committee is composed exclusively of
“independent directors” who are “financially literate” as defined under the Nasdaq listing standards. The Nasdaq
listing standards define “financially literate” as being able to read and understand fundamental financial statements, including
a company’s balance sheet, income statement and cash flow statement.

Compensation Committee

We have established the Compensation Committee,
which is composed exclusively of independent directors consisting of Paul Field, who is the Chairman of the Compensation Committee, Charles
Allen and Stephen Toovey. Each member of the Compensation Committee is a non-employee director, as defined under Rule 16b-3 promulgated
under the Exchange Act, and an outside director, as defined pursuant to Section 162(m) of the Code. Our Board adopted a Compensation
Committee Charter on March 16, 2023, which was deemed effective as of July 11, 2023. The Compensation Committee’s duties, which
are specified in our Compensation Committee Charter, include, but are not limited to:

●reviews,
                                            approves and determines, or makes recommendations to our Board regarding the compensation
                                            of our executive officers;

●administers
                                            our equity compensation plans;

●reviews
                                            and approves, or makes recommendations to our Board, regarding incentive compensation and
                                            equity compensation plans; and

●establishes
                                            and reviews general policies relating to compensation and benefits of our employees.

Nominating and Corporate Governance Committee

We have established the Nominating and Corporate
Governance Committee, which is composed exclusively of independent directors consisting of Stephen Toovey, who is the Chairman of the
Nominating and Corporate Governance Committee, Charles Allen and Paul Field. Our Board adopted a Nominating and Corporate Governance
Committee Charter on March 16, 2023, of which was deemed effective as of July 11, 2023. The Nominating and Corporate Governance Committee’s
duties, which are specified in